• Home
  • About Us
  • List of Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Healthcare Plan News Industry Clinical Trials for Ketamine and Psilocybin Drug Development

Industry Clinical Trials for Ketamine and Psilocybin Drug Development

Posted on January 31, 2022 Written by Annalyn Frame

Braxia Scientific Corp. (CSE: BRAXF (OTC: BRAXF (FWB: 4996), a medical research firm with clinics that provide innovative ketamine treatments to people with depression and other disorders, recently provided an update on its leading research role in the psychedelics sector. Braxia Scientific’s research team continues to develop innovative treatments for depression. This includes potential ketamine derivatives. Braxia Scientific also continues to conduct multiple psychedelic-based clinical trials. This adds to the Company’s growing proprietary data that will be used to inform future drug development.

Braxia Scientific has collected comprehensive data on more than 5,200 ketamine-related treatments administered at its network clinics. Braxia Scientific’s researchers published 43 manuscripts on ketamine-related topics in peer-reviewed journals. The Canadian Rapid Treatment Centre of Excellence, a Braxia subsidiary, has a growing database that contains key clinical outcomes to support an ongoing clinical trial of psilocybin assisted therapy.

Dr. Roger McIntyre is the CEO of Braxia Scientific. Braxia Scientific is a leader in the development of psychedelic drugs, thanks to its unmatched human capital, established clinical infrastructure, and large proprietary database.

“With our data and expertise, we can enhance our intellectual property. This includes our work in identifying and developing new chemical entities. Patients will have access to new treatment options for their mental disorders.

The Company’s clinical expertise has been a key factor in the expansion of the company’s infrastructure for innovative interventions, including ketamine, and psilocybin, as well as other potential future psychedelics.

The Company continues to be a leader in psychedelics, having established best practices guidelines and treatment protocols, as well as innovative therapies such as psilocybin. The publication by American Journal of Psychiatry of International Expert Opinion and Implementation Guidance by Braxia Scientific, which was written by Braxia Scientific’s leaders, illustrates the Company’s leadership. It outlines Ketamine and Esketamine treatment parameters and sets a standard for clinical implementation of rapid-acting treatment options in people with treatment-resistant depression.

Filed Under: Healthcare Plan News

Recent News

  • Health In Tech Partners with 6 Degree Health and 90 Degree Benefits January 19, 2023
  • Shockwave Therapy to Erectile Dysfunction In Celina, TX: Comprehensive Guide December 22, 2022
  • Blue Cross and Blue Shield of Minnesota Promotes Bukata Hayes to Chief Equity Officer December 22, 2022
  • Liberty HealthShare Offers Holiday Special Discount for New Members December 22, 2022
  • Blue Cross Blue Shield Of Massachusetts Signs Value-Based Payment Contracts December 15, 2022
  • EmpiRx Health Appoints Ziad Rubaie as Chief Growth Officer December 15, 2022
  • Superior HealthPlan, MedArrive & Brave Health Partnership December 15, 2022
  • Gravie Names Dr. Greg Burrell as Company’s First Chief Medical Officer December 15, 2022
  • Solis Health Plans Appoints Industry Veteran Francisco Hernandez, M.D. as Chief Medical Officer December 15, 2022
  • HealthPartners Improves Member Shopping Experiences on the ACA Marketplace December 15, 2022

About Annalyn Frame

Annalyn Frame is a Registered Nurse, currently traveling the country as a traveling nurse. She is the Editor of Health Plan News.

Search Our Site

Ketamine Therapy Dallas
Ketamine Treatment Clinic Dallas
AutoTransportAAT.com

Categories

  • AARP
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • CIGNA HealthCare
  • COVID-19
  • Facilities And Providers
  • FDA
  • Health Clinics
  • Healthcare Companies
  • Healthcare Plan News
  • MedBasics
  • Medical And Healthcare
  • Medicare
  • Senior News
  • The SCOOTER Store

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Affordable Health Insurance
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • Hormone Replacement Therapy
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Research Consultants
  • Personal Lubricants for Women – Liven Up Your Life!
  • Private Health Insurance Plans
  • Rhesus Negative
  • Self Employed Health Insurance
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Use of Post Cycle Therapy Supplements
  • Travel Health Insurance

Copyright © 2023 · Focus Pro Theme on Genesis Framework · WordPress · Log in